Abstract
The ability of the farnesyl transferase inhibitor R115777 to act as a cancer therapeutic/preventive agent and to modulate proliferation/apoptosis markers was determined in the methylnitrosourea-induced model of mammary carcinogenesis. Female Sprague-Dawley rats were given methylnitrosourea at 50 days of age. In the prevention study, R115777 (5, 16, or 50 mg/kg body weight/d), beginning 5 days after methylnitrosourea treatment, decreased the formation of mammary cancers by 6%, 42%, and 75%, respectively. Approximately 50% of the mammary cancers that developed had HaRas mutations. Only 1 of 15 tumors that grew out in the presence of R115777 (16 or 50 mg/kg body weight/d) had a HaRas mutation. In the therapeutic study, a surgical biopsy of a mammary cancer was done to determine HaRas status, and growth of the cancer was then followed during treatment of the rat with R115777. Virtually every cancer with a HaRas mutation underwent complete regression within 3 weeks, whereas tumors without a HaRas mutation had variable responses to the inhibitor. Both of these studies implied a high sensitivity of tumors with HaRas mutations to the effects of R115777. In order to understand the preferential susceptibility of tumors with HaRas mutatio...Continue Reading
References
Jan 9, 1987·Science·D J SlamonW L McGuire
Mar 15, 1968·International Journal of Cancer. Journal International Du Cancer·R H BassinJ J Harvey
Sep 1, 1968·Virology·K D Somers, W H Kirsten
Dec 15, 1983·Nature·S SukumarM Barbacid
Aug 1, 1995·Nature Medicine·N E KohlK Hamilton
Sep 23, 1998·Carcinogenesis·R A LubetC J Grubbs
May 18, 1999·Breast Cancer Research and Treatment·R A Walker, S J Dearing
Jun 9, 2000·Breast Cancer Research and Treatment·K ChristovR Lubet
Jan 10, 2001·Journal of Mammary Gland Biology and Neoplasia·J Russo, I H Russo
Feb 27, 2003·Breast Cancer Research and Treatment·Konstantin ChristovI Bernard Weinstein
Mar 19, 2003·Cancer Biology & Therapy·Adrienne D Cox, Channing J Der
Jul 29, 2003·The Journal of Biological Chemistry·James J FiordalisiAdrienne D Cox
May 28, 2004·Endocrine-related Cancer·R M O'Regan, F R Khuri
Jul 3, 2004·Cancer Research·Lynn B EckertChanning J Der
Nov 13, 2004·Breast Cancer Research : BCR·Julia Head, Stephen R D Johnston
Apr 20, 2005·Cancer Cell·Nieves MijimolleMariano Barbacid
Citations
Dec 28, 2007·Blood·Mitch RaponiJudith E Karp
Jul 16, 2014·Expert Review of Hematology·Muneera Al-Hussaini, John F DiPersio
Sep 8, 2010·Seminars in Oncology·Vernon E Steele, Ronald A Lubet
Nov 1, 2018·Journal of Cellular Biochemistry·Atena SoleimaniSeyed Mahdi Hassanian
Apr 22, 2010·Molecular Pharmacology·Chun-Ki KimYoung-Myeong Kim
May 29, 2020·Genome Medicine·Hye Won LeeWoong-Yang Park
Dec 25, 2019·Cancer Prevention Research·Ronald A LubetClinton J Grubbs
Mar 28, 2013·Cancer Prevention Research·Ronald A LubetClinton J Grubbs
Jul 11, 2007·Molecular Cancer Therapeutics·Ronald A LubetClinton J Grubbs
Apr 1, 2008·Molecular Cancer Therapeutics·Ronald A LubetClinton J Grubbs
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Konstantin ChristovRonald A Lubet